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IntroductIon
Monocytes are circulating mononuclear phagocytes and 
comprise two main subsets, which in mice have been de-
fined as CCR2+ CX3CR1int CD43lo Ly6Chi and CCR2− 
CX3CR1hi CD43hi Ly6Clo cells (Geissmann et al., 2003; 
Ginhoux and Jung, 2014; Mildner et al., 2016). Monocytes 
develop in steady state in the BM from common monocyte 
precursors (cMOPs; Hettinger et al., 2013) that themselves 
derive from monocyte/macrophage DC precursors (MDP; 
Fogg et al., 2006; Varol et al., 2007). Ly6Chi monocytes are 
short lived (Yona et al., 2013) and poised to home to sites of 
inflammation to give rise to cells with DC or macrophage 
features (Mildner et al., 2013). Ly6Clo cells are progeny of 
Ly6Chi monocytes, display more extended half-lives (Yona et 
al., 2013), and are patrolling cells specialized in surveillance 
of vascular integrity (Auffray et al., 2007). As such, Ly6Clo 
cells can be considered a blood-resident macrophage popu-
lation (Ginhoux and Jung, 2014). Infiltrates of Ly6Chi mono-
cytes are prominent in neuroinflammatory disorders, such 
as the animal model of multiple sclerosis (MS), experimen-
tal autoimmune encephalomyelitis (EAE), which involves 
blood –brain barrier breakage (Mildner et al., 2009). Emerg-
ing evidence indicates distinct functional contributions of 
monocyte-derived cells and central nervous system (CNS)–
resident microglia (Shechter et al., 2009; Ajami et al., 2011; 
Yamasaki et al., 2014).
Proinflammatory cytokines, such as IL-1β, IL-6, and 
TNF, are hallmarks of CNS inflammation (Murphy et al., 
2010). TNF has pleiotropic actions and can induce both cell 
death and apoptosis resistance (Karin and Lin, 2002). In MS 
lesions, TNF is highly abundant and produced by many cells 
(Hofman et al., 1989; Bitsch et al., 2000). TNF is synthe-
sized as a membrane-bound molecule but can be shed by the 
metalloprotease TNF-α–converting enzyme (TACE; Horiu-
chi et al., 2007). Both transmembrane and shed TNF isoforms 
have activity with partially distinct impact. Membrane-teth-
ered TNF displays higher affinity for TNFR2 (p75) and was 
proposed to predominantly promote cell survival (Grell et al., 
1995), whereas shed TNF binds preferentially to the death do-
main containing TNFR1 (p55), which may trigger apoptosis 
as shown in in vitro assays (Grell et al., 1998). Thus, TNF can 
act in diverse and even adverse ways (Caminero et al., 2011).
Using mice harboring conditional mutant TNF alleles, 
it was shown that TNF produced by myeloid cells mediates 
LPS-induced septic shock and protection from intracellular 
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pathogens (Grivennikov et al., 2005). Moreover, when 
subjected to EAE, lyzMCre :tnf fl /fl mice displayed delayed 
disease initiation, though no amelioration of the subsequent 
chronic pathology (Kruglov et al., 2011). This suggested 
a specific role of myeloid TNF in EAE onset. However, as 
the LysM promoter displays activity in both neutrophils and 
monocytes and low penetrance in microglia (Goldmann et al., 
2013), it remained unclear which myeloid cells produce the 
critical TNF and what the underlying mechanisms are.
Here, we investigate the importance of TNF signaling in 
steady-state and inflammatory monocytes. We reveal a novel 
critical role of autonomous TNF signaling as a survival fac-
tor for monocytes, both in steady state and under neuroin-
flammatory conditions. Moreover, using the CX3CR1Cre/CreER 
system (Yona et al., 2013), we investigated the relative con-
tribution of TNF derived from microglia or monocytes for 
EAE induction and show that microglial TNF is dispensable 
for EAE development. In contrast, absence of autonomous 
TNF from the monocyte infiltrate impaired survival of the 
cells and delayed EAE induction.
rEsuLts And dIscussIon
requirement of cell-intrinsic and -nonintrinsic tnF 
during monocyte development
Transcriptome analysis of monocytes and their BM precur-
sors revealed a consistent, though modest, expression of TNF, 
which increases with the steady-state differentiation of Ly6Chi 
monocytes into Ly6Clo cells (Fig.  1, A and B; unpublished 
data). Moreover, with progression from the Ly6Chi via the 
Ly6Cint to the Ly6Clo stage, monocytes gradually increased 
expression of many NF-κB signature genes, including tnf and 
its receptors tnfrsf1a (encoding TNFR1) and tnfrsf1b (encod-
ing TNFR2), as part of their conversion program (Fig. 1, A 
and B). Tnfrsf1a levels are high already at the MDP stage and 
increase moderately (about twofold) with monocyte develop-
ment, whereas tnfrsf1b displays low expression in BM precur-
sors but is ∼20-fold induced during development, peaking in 
Ly6Clo blood monocytes. Interestingly, TNF expression levels 
are significantly correlated with expression of both TNFR1 
(r = 0.597; P < 0.05) and TNFR2 (r = 0.809; P < 0.001).
TNFR1-deficient monocytes are present in similar 
numbers and subset distribution as monocytes in WT blood 
(Fig. S1 A). To probe for a potential role of TNF in monocyte 
generation and survival in a competitive setting, we generated 
mixed BM chimeras, in which lethally irradiated WT mice 
received equal amounts of WT BM (CD45.1) and BM de-
ficient for either TNF receptor 1 (TNFR1−/−) or both TNF 
receptors (TNFR1/2−/−; CD45.2; Fig. 1, C and D; and Fig. S1 
B). When analyzed after 4 wk, the blood T cell compartment 
of the chimeras displayed similar representation of both gen-
otypes. However, TNFR1−/− Ly6Chi monocytes (CD45.1/2 
ratio ∼15-fold) and, even more profoundly, TNFR1−/− 
Ly6Clo monocytes (CD45.1/2 ratio ∼50-fold) were outcom-
peted by their WT counterparts (Fig. 1 C). A similar effect 
was evident in [WT/TNFR1/2−/− > WT] BM chimeras, 
with an additive impact of the TNFR2 mutation, which was 
significant in Ly6Clo monocytes (CD45.1/2 ratio ∼75-fold), 
in line with their up-regulation of TNFR2 (Fig. 1, C and D). 
Of note, examination of monocytic BM precursors, including 
MDP, cMOP, and BM Ly6C+ monocytes, also revealed an 
overrepresentation of the WT genotype (Fig. 1 D, and Fig. 
S1, C and D). This indicates TNF requirement during mo-
nopoiesis. However, the further bias among the Ly6Clo blood 
monocytes of the [WT/TNFR1/2−/−] chimeras, together 
with the up-regulation of both TNF and TNFR2 in these 
cells, suggests an additional role of TNF in Ly6Chi to Ly6Clo 
monocyte conversion (Fig. 1 D).
These data raised the possibility that TNF has an au-
tonomous effect on monocytes. To probe more rigorously 
such a scenario, we next generated mixed BM chimeras with 
TNF−/− (CD45.2) and TNF+/+ (CD45.1) BM. Representa-
tions of TNF-sufficient and -deficient Ly6Chi blood mono-
cytes, as well as MDP, cMOP, and Ly6Chi BM monocytes, 
in these chimeras were equal, indicating no requirement of 
autonomous TNF throughout monocyte development up 
to this point (Fig.  1, E and F; and Fig. S1 E). In contrast, 
TNF-deficient Ly6Clo monocytes were significantly under-
represented as compared with TNF-sufficient monocytes 
(Fig. 1 F). Because these cells retain TNF receptor expression, 
these data imply an intrinsic requirement for cell-autono-
mous TNF by these monocytes.
Absence of tnF signaling leads to 
excessive monocyte cell death
Cell-autonomous TNF could be required for either mono-
cyte development or survival. To test the latter option, we 
resorted to an in vitro microfluidic system (Zaretsky et al., 
2012). Specifically, we isolated circulating Ly6Chi and Ly6Clo 
monocytes from WT, TNF−/−, and TNFR1−/− mice and 
co-cultured them in microwells (Zaretsky et al., 2012) in the 
presence of the dead cell marker propidium iodide (PI) for 
48  h (Fig.  2  A). Co-culture of WT and knockout mono-
cytes in separate microwells in the same array allows for direct 
comparison of their death rate and survival, with single-cell 
resolution. In this assay, cells can initially respond only to 
TNF they secrete themselves; at later time points though, 
TNF can diffuse from TNF-secreting cells and affect cells in 
neighboring microwells with a typical diffusion time between 
wells of ∼24 h. The single-cell real-time analysis for cell death 
revealed that monocytes deprived of TNFR1 died signifi-
cantly more rapidly than their WT counterpart, including 
both Ly6Chi and Ly6Clo cells. Moreover, the fraction of cells 
surviving 48 h in culture was significantly lower compared 
with TNFR1-sufficient monocytes (Fig.  2, B–E). A similar 
result was obtained with TNF-deficient Ly6Chi monocytes, 
which also exhibited faster death rates. However, the fraction 
of surviving cells at the end of the assay was similar to that of 
WT monocytes, probably because of TNF secreted by WT 
monocytes diffusing from neighboring microwells (Fig.  2, 
C–E). Earlier studies demonstrated that low doses of TNF 
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can promote myeloid cell survival (Cowburn et al., 2004; 
Lehner et al., 2012). After administration of 2.5 ng/ml exog-
enous recombinant TNF, both TNF-sufficient and -deficient 
Ly6Chi monocytes were indeed partially rescued, as evident 
by a twofold increase of thalf, the time point at which the 
fraction of dying cells reached half of its maximal value, in 
both genotypes (Fig.  2  F; see Materials and methods for a 
description of thalf calculation). This effect was less substan-
tial with a higher TNF dose (50 ng/ml; Fig.  2  F). Mixed 
cultures of MACS (magnetic-activated cell sorting)-sorted 
CD11b+CD115+ BM monocytes from TNFR−/− (CD45.2) 
and TNF−/− (CD45.1) mice, treated with the macrophage 
differentiation factor M-CSF, showed no disadvantage of the 
TNFR1-deficient cells, indicating that autonomous TNF is 
Figure 1. Absence of tnF signaling impairs steady-state monocytes. (A) Scheme illustrating monocyte development (top) and heat map of RNA 
sequencing expression data of NF-κB–driven genes in sorted MDP, cMOP, and Ly6Chi BM monocytes, as well as Ly6Chi, Ly6Cint, and Ly6Clo blood monocytes 
(bottom). (B) RNA sequencing reads for tnf, tnfrsf1a, and tnfrsf1b expression throughout sequential monocyte development stages in A. n = 2–3. (C) FACS 
analysis of T cells and Ly6Chi and Ly6Clo monocytes (MO) extracted from blood of either [TNFR1−/−/WT > WT] (top) or [TNFR1/2−/−/WT > WT] (bottom) 
mixed BM chimeras. (D) Quantification of myeloid cells and precursors. n = 3–5. Mann-Whitney U test was used. (E) FACS analysis of Ly6Chi and Ly6Clo 
monocytes extracted from blood of [TNF/WT > WT] mixed BM chimeras. (F) Quantification of myeloid cells and precursors in C and D. n = 5–10. Student’s 
t test was used. *, P < 0.05.
o
n
 April 27, 2017
D
ow
nloaded from
 
Published March 22, 2017
Autonomous TNF in monocyte survival | Wolf et al.908
dispensable for monocyte-derived macrophage differentia-
tion (Fig.  2 G). In addition, cMOPs isolated from TNF−/− 
(CD45.2) and TNF+/+ (CD45.1) mice displayed similar death 
rates and fractions of surviving cells, indicating that autono-
mous TNF is not required for monopoiesis (Fig. 2, H and I), 
corresponding to lack of TNF expression in cMOPs (Fig. 1, 
A and B). To relate these findings to the in vivo setting, we 
performed a staining for surface phosphatidylserine, as an in-
dicator of cell death induction, on blood monocytes of the 
mixed chimeras. Interestingly, mutant Ly6Clo monocytes in 
[WT/TNF−/− > WT] and [WT/TNFR1−/− > WT], i.e., cells 
deficient for either the cytokine or its receptor, displayed in-
creased annexin V staining for the apoptotic marker as com-
pared with WT cells, indicating that autonomous TNF is 
required for monocyte survival in vivo (Fig. 2, J and K).
In conclusion, the data obtained from the competitive 
in vivo experiments and the single-cell in vitro analysis estab-
lished the requirement of autonomous TNF production of 
monocytes for their survival.
Ly6chi effector monocytes up-regulate 
tnF and tnFr1 during EAE
Monocyte infiltrates have been shown to play a critical role 
in the establishment of EAE that is distinct from microg-
lia (Mildner et al., 2009; Ajami et al., 2011; Yamasaki et al., 
2014). To investigate potential roles of monocyte- or macro-
phage-derived TNF in EAE development and probe for the 
physiological importance of the autonomous loop, we iso-
lated the monocytic spinal cord infiltrate defined as CD45hi 
CD11b+ Ly6Chi Ly6G− cells, hereafter termed effector 
monocytes (Mildner et al., 2013), from EAE-induced mice at 
the pre–EAE onset stage (day 9 after immunization; score 0; 
Fig. 3 A). The time point before onset of EAE paralysis was 
chosen to minimize secondary effects induced by demye-
lination and cell death. Comparative transcriptome analysis 
with Ly6Chi steady-state monocytes (Lavin et al., 2014) re-
vealed a list of 440 genes up-regulated in spinal cord effec-
tor monocytes compared with steady-state monocytes and 
133 down-regulated genes, after filtering for genes displaying 
an absolute >1 log expression difference and p-value <0.01 
(Fig.  3 B, and Tables S1 and S2). Canonical pathway anal-
ysis showed significant enrichment for inflammatory path-
ways, such as TLR, IL-6, and TREM1 signaling, as well as 
Fcγ receptor-mediated phagocytosis and nitric oxide and re-
active oxygen species production (Fig. 3 C). Among the genes 
up-regulated was csfr2b, encoding the GM-CSF receptor and 
recently shown to drive proinflammatory monocyte activ-
ity in EAE (Croxford et al., 2015), as well as nr4a1, which 
negatively regulates monocyte pathology in EAE (Shaked 
et al., 2015); moreover, we noted high expression of tnfrsf1a 
(TNFR1) and the nuclear protein mki67, indicating prolif-
eration, as previously reported (Fig. 3, B and C; Ajami et al., 
2011). Although only modestly expressed, TNF also was sig-
nificantly induced in effector monocytes, as compared with 
robust myeloid genes such as emr1 (encoding the F4/80 anti-
gen), which was equally highly expressed in both populations 
(Fig. 3 D). Of note, TNFR2 levels were moderately reduced 
in effector monocytes (Fig. 3 D).
Monocyte- but not microglia-derived tnF 
is critical for EAE onset
The up-regulation of TNF and TNFR1 in effector mono-
cytes mirrored the induction paralleling the generation 
of Ly6Clo blood monocytes, suggesting a similar survival 
mechanism. To study the role of TNF expression for the 
function of mononuclear phagocytes in the context of 
EAE, we crossed cx3cr1Cre and cx3cr1CreER animals (Yona et 
al., 2013) to mice harboring floxed tnf alleles (Grivennikov 
et al., 2005). The cx3cr1Cre system broadly affects tissue 
macrophages, as well as monocyte-derived cells and a fraction 
of DCs (Yona et al., 2013; Aychek et al., 2015). However, the 
tamoxifen (TAM)-inducible cx3cr1CreER system targets long-
lived cells that express the CX3CR1 chemokine receptor at 
the time of TAM treatment. The latter includes microglia 
and nonparenchymal CNS macrophages (Goldmann et al., 
2016) but excludes monocytes (Goldmann et al., 2013) and 
hence allows discrimination of microglial and monocyte-
derived TNF. First, we investigated the EAE disease course in 
cx3cr1Cre :tnffl /fl animals. To confirm the broad TNF deletion 
in tissue macrophages and monocytes, we challenged the 
animals with LPS, which is known to result in systemic TNF 
release (Grivennikov et al., 2005). Cx3cr1Cre :tnf fl /fl mice 
displayed 4 h after intraperitoneal LPS challenge significantly 
lower serum TNF levels than littermate controls (Fig. 3 E). 
To probe for EAE development in cx3cr1Cre :tnf fl /fl mice, 
we immunized the animals with MOG35–55 peptide and 
monitored disease emergence up to day 70. Total myeloid-
derived TNF was significantly reduced in cx3cr1Cre :tnf fl /fl 
mice in the spinal cord at EAE day 24 (Fig.  3  F), and 
TNF signal was abolished in both resident microglia and 
CD45hiLy6Chi and CD45hiLy6Clo monocytic infiltrates (Fig. 
S2 A). In accordance with earlier studies performed with 
TNF−/− animals (Kassiotis and Kollias, 2001; Kruglov et al., 
2011), cx3cr1Cre :tnf fl /fl mice exhibited a delayed and less sharp 
EAE onset (mean day 31), as compared with TNF fl/fl controls, 
which showed an earlier and synchronized start (mean 14 
d; Fig.  3, G and H). However, eventually, the severity of 
disease symptoms was comparable between the mutants and 
littermate controls, both with respect to the mean maximal 
score and extent of demyelination (Fig. 3  I and Fig. S2 E). 
Of note, when animals from several EAE experiments were 
pooled together, statistically significant effects were seen both 
with respect to disease onset and maximal severity, which was 
slightly reduced in cx3cr1Cre :tnf fl /fl animals (Fig. S2 B).
EAE development relies on generation of autoreactive 
CD4+ effector T cells, triggered by peripheral, and potentially 
also CNS-associated, DCs (Codarri et al., 2013). Delayed 
disease onset could indicate impaired T cell priming. However, 
analysis of lymph node T cells (day 6 after immunization) and 
spinal cord T cells of diseased animals (days 13 and 24) revealed 
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Figure 2. Absence of tnF signaling increases apoptosis of circulating monocytes. (A) Scheme of in vitro co-culturing of TNF/TNFR1-deficient and WT 
monocytes in microwells. (B) Traces of co-cultured WT (TNFR1+/+) and TNFR1−/− monocytes monitored in culture for 48 h. WT/TNFR1−/− cells were distin-
guished by fluorescently labeled antibodies against CD45.1/CD45.2, respectively. Cell death time was monitored using PI. Bar, 10 μm. (C and D) Cumulative 
fraction of dead monocytes (PI+) during 48 h (C) and timing of PI signal (indicating time of cell death) for individual cells (D) in co-cultures of: Ly6Chi WT/
TNFR1−/− monocytes (n = 567 and 960 cells, respectively), Ly6Chi WT/TNF−/− (n = 641 and 1,348), Ly6Clo WT/TNFR1−/− (n = 1,567 and 1,766), and Ly6Clo WT/
TNF−/− (n = 1,121 and 1,162). Red lines in D show means. **, P < 0.01; ***, P < 0.001. Mann-Whitney U test was used. (E) Fraction of monocytes surviving 
after 48 h of co-culture. ***, P < 0.001. χ2 test was used. (F) Cumulative fraction of dead (PI+) Ly6Chi WT/TNF−/− monocytes co-cultured in microwell arrays 
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similar numbers of CD4+ effector T cells, as well as T helper 
1 cell (Th1 cell) and Th17 cell prevalence in cx3cr1Cre :tnf fl /fl 
and tnf fl/fl mice. In addition, histology revealed no significant 
difference in CD3+ cell numbers (Fig. S2, F and G). Finally, 
in vitro recall responses of lymph node CD4+ effector T cells 
to secondary exposure to MOG35–55 peptide, measured by the 
percentage of CD44+ cells, were unaffected in cx3cr1Cre :tnf fl /fl 
mice (Fig. S2 H). Thus, the CD4+ T cell compartment of 
cx3cr1Cre :tnf fl /fl mice is seemingly intact.
To investigate whether the EAE delay we observed 
in cx3cr1Cre :tnf fl /fl mice was caused by a lack of TNF 
production by monocyte-derived phagocytes or tissue-
resident microglia, we resorted to the cx3cr1CreER system 
(Yona et al., 2013). First, we isolated microglia from 
TAM-treated tnf fl/fl and cx3cr1CreER :tnf fl /fl animals and 
challenged them ex vivo with 10 µg/ml LPS for 4 h. Tnffl/fl 
microglia responded to stimulation with robust induction 
of TNF, whereas cx3cr1CreER :tnf fl /fl microglia failed to do 
so, confirming their lack of the tnf gene (Fig. S3 A). To 
investigate the impact of the microglial TNF deficiency on 
EAE development, tnf fl/fl and cx3cr1CreER :tnf fl /fl animals 
were immunized 6 wk after TAM treatment with MOG35–
55 peptide in CFA. Spinal cord microglia obtained from 
MOG35–55-immunized cx3cr1CreER :tnf fl /fl mice lacked TNF 
production (Fig. S3, B and C). However, despite the prominent 
TNF expression in WT microglia, cx3cr1CreER :tnf fl /fl 
mice displayed an EAE disease course similar to that of 
littermate controls, both with respect to severity and onset 
(Fig. S3, D–F). No statistically significant change in day 
of onset or maximal severity was seen even when animals 
from several experiments were pooled together, despite a 
nonsignificant trend of reduced mortality in cx3cr1CreER :tnf fl /fl 
animals (Fig. S3, G and H). This establishes that microglial 
TNF is dispensable for EAE initiation in the MOG35–55 
peptide/CFA-induced C57BL/6 model.
Monocytic infiltrates are reduced in the 
absence of autonomous tnF
Neither peripheral T cell priming nor CNS infiltration of 
T cells seemed to depend on mononuclear phagocyte-
derived TNF, and the microglia-restricted TNF deletion 
did not alter the disease course. Hence, we focused on the 
role of TNF production by CNS-infiltrating monocytes. 
In steady state, blood monocytes of cx3cr1Cre :tnf fl /fl mice 
display normal numbers (Fig. S2 C). A fraction of the WT 
(tnf fl/fl) effector monocyte infiltrate in the spinal cords of 
diseased animals displayed TNF expression; however, as 
expected, the latter was absent from effector monocytes of 
cx3cr1Cre :tnf fl /fl mice (Fig. 4 A). Notably though, at day 9 after 
MOG immunization, i.e., before disease onset, and on day 
24, effector monocyte numbers in spinal cords were found 
significantly reduced in cx3cr1Cre :tnf fl /fl mice, as compared 
with controls (Fig. 4, B and C). However, effector monocytes 
of cx3cr1Cre :tnf fl /fl mice expressed normal levels of MHC 
II, indicating similar activation of the cells in the absence of 
TNF (Fig. S2 D). Thus, we observed a positive correlation 
between numbers of Ly6Chi effector monocytes and their 
TNF expression and EAE onset.
The reduced number of infiltrating monocytes in 
the spinal cords of cx3cr1Cre :tnf fl /fl mice could stem from 
environmental impairment, such as reduced activation 
of endothelial cells, which are known to depend on TNF 
(Madge and Pober, 2001) and recruit monocytes via the 
CCL2/CCR2 axis (Paul et al., 2014). However, CD31+ 
CD45− endothelial cells isolated from spinal cord of MOG-
challenged cx3cr1Cre :tnf fl /fl mice and controls up-regulated 
expression of VCAM1, suggesting an unaltered endothelial 
response (Fig. S2 I). Alternatively, the reduction of effector 
monocytes in cx3cr1Cre :tnf fl /fl mice could result from 
autonomous TNF-mediated survival, similar to that observed 
for steady-state Ly6Clo monocytes. To probe this option, 
we generated mixed BM chimeras with cx3cr1Cre :tnf fl /fl 
(CD45.2) and cx3cr1gfp :tnf + /+ (CD45.1) BM. [Cx3cr1Cre 
:tnf fl /fl /cx3cr1gfp :tnf + /+ > WT] mice were immunized with 
MOG peptide in CFA. Analysis of effector monocytes in 
the spinal cord 9 d after MOG immunization revealed an 
extensive out-competition of the TNF-deficient by the 
TNF-proficient (CD45.1) effector monocytes (Fig.  4  D). 
Interestingly, in dextran sulfate sodium (DSS)–induced colitis, 
an inflammatory condition in which monocytes do not up-
regulate TNF (Zigmond et al., 2012), colonic Ly6Chi CD45.2 
tnf −/− monocytes were represented in the same percentages 
as steady-state Ly6Chi blood monocytes, indicating that not all 
inflammatory conditions require autonomous TNF survival 
signal (Fig. S1 F). Collectively, these data show that absence 
of the autonomous TNF signal can have a critical impact on 
the performance of effector monocytes in both steady-state 
and inflammatory settings.
Here, we report the critical role of cell-intrinsic 
TNF for the survival and function of blood and effector 
monocytes in steady state and in a model of autoimmune 
neuroinflammation. The concept of cell-autonomous/
during 48 h without TNF (n = 80 and 164) or with 2.5 ng/ml (n = 192 and 142) or 50 ng/ml (n = 112 and 181) recombinant TNF (rTNF). Closed and open 
circles show data (WT and TNF−/−, respectively), and continuous and dashed lines represent the best-fit logistic curve (see Materials and methods). The table 
shows thalf, the time by which the curves reach half of their maximum value. (G) FACS analysis of mixed cultures of MACS-sorted CD115+CD11b+ BM cells 
of CD45.1 and CD45.1/CD45.2 TNFR1−/− mice in the presence of 10 ng/ml M-CSF. Data are representative of three biological repeats. rM-CSF, recombinant 
M-CSF. (H and I) Timing of PI signal for individual cells (H) and fraction of cells surviving after 48 h (I) of cMOPs sorted from BM of WT and TNF−/− mice, 
co-cultured in microwell arrays. n = 47 and 170. (J and K) Fraction of annexin V+ Ly6Clo monocytes in BM chimeric [TNF/WT > WT] (F) and [TNFR1−/−/WT > 
WT] (G). n = 9–10. ***, P < 0.001. Paired Student’s t test was used.
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Figure 3. total monocyte/macrophage tnF deletion affects EAE onset. (A) Gating strategy for spinal cord–infiltrating effector monocytes, used for all 
cell sorting and analysis. (B) Volcano plot performed for comparison of sorted steady-state blood monocytes and effector monocyte infiltrates in the spinal 
cord at EAE day 9. Numbers indicate genes significantly up-regulated (red) or down-regulated (green) in effector monocytes compared with steady-state 
monocytes (log difference >1 or <−1; P < 0.05). (C) Canonical pathway analysis performed for genes significantly changed in D. Z-score >2 or <−2. iNOS, 
inducible nitric oxide synthase; NO, nitric oxide; PLK, polo-like kinase; PPAR, peroxisome proliferator-activated receptor; ROS, reactive oxygen species. (D) 
Normalized reads of tnf, tnfsr1a, tnfrsf1b, and emr1 expression in steady state and effector monocytes, as in Fig. 2 E. n = 3–4. Mann-Whitney U test was 
used. (E) ELI SA of sera collected from tnf fl/fl and cx3cr1Cre :tnf fl /fl mice 4 h after intraperitoneal challenge with 200 µg LPS in vivo. n = 5. Mann-Whitney U 
test was used. (F) TNF production by myeloid cells in spinal cords of tnf fl/fl and cx3cr1Cre :tnf fl /fl mice at day 24 after MOG35–55 immunization, analyzed by 
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autocrine TNF signals has been discussed before in different 
cellular contexts. In cultured human monocyte-derived 
DCs, autocrine TNF was shown to inhibit apoptosis 
mediated by LPS and polyinosinic :polycytidylic acid, by 
regulating the balance between pro- and antiapoptotic 
proteins (Cowburn et al., 2004; Lehner et al., 2012). 
CpG-induced autocrine TNF of BM-derived mouse 
macrophages was suggested to amplify NF-κB activation 
(Caldwell et al., 2014). Moreover, LPS stimulation of these 
cells was recently shown to induce cell-intrinsic TNF-
mediated necroptosis, if not inhibited by CYLD (Legarda 
et al., 2016). These experiments used primary cell cultures 
to dissect paracrine from autocrine TNF secretion. 
However, experimental evidence supporting the in vivo 
relevance and physiological implications of self-TNF and 
its impairment has been missing.
Specifically, here, we demonstrate that prosurvival sig-
naling triggered by autonomous TNF is important for mono-
cyte differentiation and monocyte maintenance. Of note, in 
the EAE model, inflammatory signals, which activate Ly6Chi 
monocytes and recruit them to the site of inflammation, also 
initiate autocrine TNF as well as TNFR1 expression. More-
over, TNF is found to be up-regulated after the conversion of 
Ly6Chi monocytes into Ly6Clo cells in the steady state, along-
side the induction of its receptors, especially TNFR2. The 
TNF-triggered signal seems also important for the survival of 
effector Ly6Chi monocytes infiltrating the spinal cord, as, in 
its absence, CNS monocyte numbers are reduced, and EAE 
disease development is delayed. Interestingly, BM monocyte 
precursors also require TNF, as indicated by the disadvantage 
of TNFR1-deficient cells compared with WT, but can ac-
quire TNF from noncell-intrinsic origins and do not seem to 
express autonomous TNF.
Notably, we find TNF to be produced at levels that are 
detectable by flow cytometry only in a small fraction of effec-
tor monocytes; likewise, Ly6Clo monocytes also express low 
amounts of TNF. However, interestingly, it has been reported 
that low concentrations of TNF, which could escape our 
readout, can promote survival, whereas high concentrations 
can confer apoptosis and collateral damage (van den Berg et 
al., 2001). This paradoxical effect of TNF on monocytes, i.e., 
promotion of survival or apoptosis at low and high levels, 
respectively, is reminiscent of an IL-2 activity on T cells that 
we recently revealed as a mechanism that contributes to cell 
number homeostasis (Hart et al., 2014).
Although the deletion of myeloid TNF results in re-
duced monocyte numbers in the tissue, it does not signifi-
cantly alter the extent of tissue damage caused by EAE; thus, 
monocyte-derived TNF is not required for demyelination 
itself. Likewise, microglial TNF is not required for the in-
duction of EAE, probably because the massive generation 
of monocyte-derived macrophages can compensate for the 
loss of microglial TNF.
TNF is known primarily as a proinflammatory cytokine 
and a mediator of apoptosis (Wajant et al., 2003). However, 
TNF signaling activates the NF-κB signaling pathway, which 
also includes many genes promoting cell survival and inhib-
iting cell death by apoptosis (Karin and Lin, 2002). In human 
neutrophils, TNF can induce survival in an NF-κB–depen-
dent manner (Cowburn et al., 2004). Moreover, human DCs 
were proposed to be protected by autocrine TNF from apop-
tosis, although in the performed in vitro assays, TNF provision 
by neighbor DCs could not be ruled out (Lehner et al., 2012).
Importantly, our study focuses on EAE disease onset. As 
our work is confined to C57BL/6 mice, we were bound to 
MOG35–55 peptide vaccination and can draw no conclusions 
on a relapsing/remitting EAE course, which might argu-
ably better reflect the disease progression in humans (Berard 
et al., 2010). Future work using SJL mice and other pep-
tides, such as proteolipid protein and myelin basic protein, 
will be required to elucidate the roles of myeloid TNF in 
the remyelination process and of monocytic or microglial 
TNF in EAE reoccurrence.
An even more important question is whether the in-
trinsic TNF survival mechanism we report exists in human 
monocytes. TNF antagonist so far proved to be inefficient or 
even detrimental in EAE (Caminero et al., 2011). However, 
our data suggest that neutralization of monocytic TNF, either 
by a specific antagonist or by blockade of the corresponding 
receptor, could be tested clinically for its potential to amelio-
rate MS in humans. Of particular interest in this respect are 
newly developed bispecific antibodies designed to specifically 
neutralize monocyte/macrophage TNF (Efimov et al., 2016). 
TNFR1−/− mice are protected from EAE, and selective neu-
tralization of TNFR1 with antibody reduces disease sever-
ity (Williams et al., 2014). An alternative promising approach 
could be the monocyte-specific knockdown of TNF or its 
receptors by nanoparticle-encapsulated siRNA, as recently 
demonstrated for CCR2 (Majmudar et al., 2013).
To conclude, here, we describe a novel role for cell-in-
trinsic TNF in the survival of monocytes under both steady-
state and pathological conditions. We show that this autocrine 
signal can alter significantly the disease course in autoimmune 
demyelination and potentially other conditions that involve 
acute recruitment of effector monocytes.
MAtErIALs And MEthods
Mice
The following 4–24-wk-old mice were used: C57BL/6 
(CD45.2 and CD45.1; B6.SJL-Ptprca Pep3b/Boyj; Jackson 
FACS. n = 7–4. Mann-Whitney U test was used. (G–I) EAE disease course (G), day of onset (H), and individual maximal score (I) in tnf fl/fl and cx3cr1Cre :tnf fl /fl 
mice immunized with MOG35–55 peptide. n = 7–8. Student’s t test was used. Data are representative of three independent experiments. *, P < 0.05; **, P < 
0.01. Results are expressed as means ± SEM.
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ImmunoResearch Laboratories, Inc.), cx3cr1gfp/+ (JAX stock 
005582 B6.129P-Cx3cr1tm1Litt/J; Jung et al., 2000), cx-
3cr1Cre (JAX stock 025524 B6J.B6N[Cg]-Cx3cr1tm1.1[cre]
Jung/J), cx3cr1CreER (JAX stock 020940 B6.129P2[C]-Cx-
3cr1tm2.1[cre/ERT2]Jung/J; Yona et al., 2013), tnf f/f 
(Grivennikov et al., 2005), tnf −/− (Pasparakis et al., 1996), 
tnfrsf1a−/− (TNFR1−/−; Rothe et al., 1993), and tnfrsa1b−/−/
tnfrsf1b (TNFR1/2 DKO) mice (Probert et al., 2000). All an-
imals were on a C57BL/6 background, maintained in specific 
pathogen–free conditions, and handled according to proto-
cols approved by the Weizmann Institute Animal Care Com-
mittee as per international guidelines.
In vitro monocyte assays
Blood monocytes and BM cMOPs were sorted using a FAC 
SAria cell sorter (BD). Microwell arrays were designed using 
autoCAD (Autodesk Inc.) as an array of several hundreds of 
hexagonally spaced microwells, each being 25 µm in diameter 
and 60 µm in depth. Polydimethylsiloxane microwell arrays 
were fabricated using soft lithography as described previously 
(Zaretsky et al., 2012). The arrays were placed in glass-bot-
tom 96-well plates. Monocytes were sorted and loaded into 
the microwell array: First, medium was removed and replaced 
with 25 × 103 monocytes in 100 µl RPMI medium. The plate 
was centrifuged at 300  g for 1 min to allow cells to settle 
in the microwells. Residual cells were aspirated, and wells 
were supplemented with 200  µl RPMI containing 0.5 ng 
anti-CD45.2–Alexa Fluor 488 and 0.5 ng anti-CD45.1–
APC (BioLegend) and 2.5 µg/ml PI (Sigma-Aldrich) for 
a final dilution of 1:2 × 105 for the antibodies and 1:2 × 
103 for PI (Zaretsky et al., 2012; Polonsky et al., 2016). For 
time-lapse experiments, a Ti-Eclipse microscope (Nikon) 
was used, equipped with an automated stage, incubator, and 
closed chamber that allows for CO2 flow over the 96-well 
plate. Cells were imaged using a 20× objective and moni-
tored using brightfield illumination and three fluorescence 
channels: FITC, Cy3, and Cy5. Time-lapse videos were col-
lected using iQ software (Andor Technology). Image analysis 
was performed using a custom built MAT LAB tool. Only 
microwells that included a single cell were included in the 
analysis. Analysis was performed in several steps: (a) identifi-
cation of microwells using edge detection in the brightfield 
images, (b) background subtraction and illumination correc-
tion of fluorescent images, (c) identification of microwells, in 
which mean fluorescent intensities (MFIs) corresponded to 
that of a single cell (MFI values of single cells were evaluated 
manually for several hundreds of microwells in three different 
fields of view), and (d) death times were determined for each 
microwell as the time in which MFI in the Cy3 channel (PI 
signal) was ≥500. thalf, the time in which the cumulative death 
curve reaches half of its maximum value, was calculated by 
fitting the logistic equation
  y =  M _________ 
1 +  e −r×  ( t−​t half )  
, 
Figure 4. Effector monocytes are reduced because of absence of 
autonomous tnF. (A) FACS analysis of effector monocytes gated as in 
Fig.  3  A from MOG35–55 immunized in tnf fl/fl and cx3cr1Cre :tnf fl /fl mice at 
day 24. n = 4–7. Mann-Whitney U test was used. (B and C) FACS analysis 
of spinal cord CD45hiLy6Chi infiltrate in MOG35–55 immunized in tnf fl/fl 
and cx3cr1Cre :tnf fl /fl mice at day 9 (n = 5–7; B) or 24 (n = 4–7; C) after 
immunization. Mann-Whitney U test was used. (D) FACS analysis circulating 
steady-state (s.s.) Ly6Chi monocytes (gated as in Fig. S1 B) compared with 
spinal cord effector monocytes (gated as in Fig. 3 A) at day 9 after MOG35–55 
immunization in [CD45.1 cx3cr1gfp :tnf + /+ /CD45 .2 cx3cr1Cre :tnf fl /fl > CD45.2 
WT] chimeric mice. Resident CD45.2+ microglia (gated as in Fig. S3 B) are 
presented as reference cells for CD45.2 signal. n = 6. Student’s t test was 
used. *, P < 0.05; ***, P < 0.001.
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in which M is the maximum value, and r is the steepness of 
the slope. Fitting was done using MAT LAB. For the genera-
tion of monocyte-derived cells, BM of CD45.1 and CD45.2/
tnf −/− mice was extracted and flushed with PBS. The BM 
suspension was incubated with biotinylated CD115 antibody 
(BioLegend) and was MACS sorted using streptavidin beads 
(Miltenyi Biotec). The sorted cells were grown in RPMI me-
dium containing 10% FCS, 1% l-glutamine, 1% penicillin/
streptomycin, and 10 ng/ml M-CSF (PeproTech).
Generation of BM chimeras
7–10-wk-old recipient animals were lethally irradiated (950 
rad) and reconstituted with donor BM by i.v. injection of 
a minimum of 106 BM cells. Donor BM was isolated from 
femurs and tibiae of donor mice, filtered through a 70-µm 
mesh, and resuspended in PBS for i.v. injection.
reagent administration
TAM (Sigma-Aldrich) was dissolved in 10% ethanol/90% 
corn oil (Sigma-Aldrich) to a 100 mg/ml final solution. 
To induce Cre-mediated gene recombination in 5–7-wk-
old cx3cr1creER :tnf f /f mice, 5 mg TAM was administered 
orally for five consecutive days (25 mg total) by gavage. For 
EAE induction, mice were injected into each flank with 
50  µl emulsion containing 1 mg/ml MOG35–55 peptide 
(GeneScript), 1:4 PBS, and 1:2 Freund’s incomplete adjuvant 
(Sigma-Aldrich) enriched with killed Mycobacterium 
tuberculosis (BD), supplemented with 250 ng pertussis 
toxin (Sigma-Aldrich) administered i.p. on days 0 and 2. For 
DSS-induced colitis, mice were administrated 2% DSS (MP 
Biomedicals) in drinking water for 7 d (Zigmond et al., 2012).
EAE assessment
EAE was assessed according to an accepted assessment index 
(Stromnes and Goverman, 2006). The mice were monitored 
daily by being held at the base of the tail. The index is as 
follows: 0, no symptoms; 0.5, partial tail limp; 1, complete 
tail limp; 1.5, impaired gait; 2, loss of pinch reflex in hind-
limbs; 2.5, one hindlimb paralysis; 3, complete hindlimb 
paralysis; 3.5, one forelimb paralysis; 4, complete forelimb 
paralysis; and 5, death.
tissue extraction and flow cytometry
For peripheral analysis, blood was collected by tail bleeds; 
mononuclear cells were enriched by Ficoll density gradient 
centrifugation at 1,000 g for 15 min at 20°C with low accel-
eration and no brake. For lymph node analysis, tissues were 
collected and digested for 1 h with 1 mg/ml collagenase D 
(Roche) in PBS containing magnesium and calcium (PBS+/+; 
Beit Ha’emek) and then macerated mechanically and filtered 
through a 70-µm mesh. For CNS analysis, mice were per-
fused with 10 ml PBS via the left ventricle. Brain and spinal 
cord samples were harvested from individual mice, and tissues 
were homogenized and incubated with an HBSS solution 
containing 2% BSA (Sigma-Aldrich), 1 mg/ml collagenase D 
(Roche), and 0.15 mg/ml DNase1, filtered through a 70-µm 
mesh. Homogenized sections were resuspended in 40% per-
coll before density centrifugation (1,000 g for 15 min at 20°C 
with low acceleration and no brake). For spinal cord endo-
thelium extraction, spinal cords were removed as for microg-
lia extraction and digested with 0.1 mg/ml collagenase 11, 
2 mg/ml collagenase 2, 0.2 mg/ml Dnase1, and 0.1 mg/ml 
hylurodinase 1 (Sigma-Aldrich). After cell suspension, cells 
were incubated in FACS buffer (PBS with 1% BSA, 2 mM 
EDTA, and 0.05% sodium azide) in the presence of stain-
ing antibody. For colon extraction after DSS, fecal content 
was flushed out with PBS, and the tissue was first incubated 
with HBSS containing 10% FCS, 2.5 mM EDTA, and 1 mM 
dithiothreitol. Next, the tissue was incubated with PBS con-
taining 5% FCS, 1 mg/ml collagenase VIII (Sigma-Aldrich), 
and 0.1 mg/ml DNase I (Roche). For intracellular staining, 
the CytoFix/Cytoperm kit (BD) was used according to the 
instructions of the manufacturer. Cells were acquired on 
FAC SCanto, LSR II, and LSRFortessa systems (BD) and 
analyzed with FlowJo software (Tree Star). For cell sorting, 
the FAC SAria cell sorter (BD) was used. Antibodies used 
throughout the research are: CD11b (clone M1/70), CD45.1 
(clone A20), CD45.2 (clone 104), B220 (clone RA3-6B2), 
CD115 (clone AFS98), Gr1 (clone RB6-8C5), Ly6C (clone 
AL21), Ly6G (clone H129.19), CD4 (clone H129.19), CD45 
(clone 30F11), IL-17A (clone TC11-18H10.1), IFN-γ (clone 
XMG1.2), TNF (clone MP6-XT2), CD31 (clone 390), CD3 
(clone 145-2C11), CD19 (clone 1D3/CD19), NK1.1 (clone 
PK136), VCAM1 (clone 429 MVC AM.A; all BioLegend), 
and F4/80 (clone BM8; Serotech).
rnA isolation, library construction, and analysis
RNA sequencing was performed as described previously (Jai-
tin et al., 2014). In brief, 103–104 cells from each population 
were sorted into 100–200 µl of lysis/binding buffer (Thermo 
Fisher Scientific). mRNA was captured with 12 µl of Dy-
nabeads oligo(dT) (Thermo Fisher Scientific), washed, and 
eluted at 70°C with 10 µl of 10 mM Tris-Cl, pH 7.5. A mean 
of four million reads per library was sequenced and aligned 
to the mouse reference genome (NCBI 37; mm9) using To-
pHat (v2.0.10) with default parameters. Expression levels 
were calculated and normalized using ESAT software. RNA 
sequencing analysis focused on genes in the 25th percentile 
of expression with a twofold differential between at least two 
populations and a p-value <0.01. Canonical pathway analysis 
was performed using the Ingenuity program.
Ex vivo stimulation
For Th1/Th17 cell stimulation, spinal cord or lymph node 
samples were prepared as mentioned in the Tissue extraction 
and flow cytometry section and were incubated for 3 h in 
RPMI medium containing 10% FCS, 1:100 penicillin strep-
tomycin antibiotic, 1:100 l-glutamine, 1:100 MEM, and 1:100 
sodium pyruvate (Beit Ha’emek) supplemented with 20 µg/
ml MOG35–55 peptide (GeneScript). Then, the cell suspen-
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sions were further incubated with the same media, supple-
mented with 1 µg/ml brefeldin A (Sigma-Aldrich), for three 
additional hours before antibody staining. For ex vivo LPS 
stimulation, brain cell suspensions were incubated with the 
above RPMI medium supplemented with 10 µg/ml LPS 
for 2  h, followed by incubation in the presence of brefel-
din A for an additional 2 h. Recombinant mouse TNF was 
purchased from PeproTech.
histology
Histology was performed as described recently (Goldmann et 
al., 2013). In brief, mice were killed on day 24 after immuni-
zation and subsequently perfused with PBS. Subsequently, the 
spinal cords were removed, fixed in 4% buffered formalin, and 
embedded in paraffin. Then, tissue samples were sectioned 
and stained with Luxol fast blue (LFB-PAS) to assess the 
degree of demyelination and CD3 (1:100; MCA1477; AbD 
Serotec) to assess the degree of infiltration of T cells. Tissue 
sections were evaluated on a microscope (BX-61; Olympus) 
using cell-P software (Olympus).
ELI sA
For ELI SA, sera were extracted by tail bleed and centrifu-
gation of blood at full speed for 7 min. TNF was measured 
using the DueSet kit (R&D Systems). ELI SA was performed 
according to the manufacturer’s instructions.
statistical analysis
Results are expressed as means ± SEM. Statistical analysis 
was performed using Student’s t test, Mann-Whitney U test, 
ANO VA, or repeated-measurements two-way ANO VA with 
posthoc Student’s t test or paired Student’s t test, as appropri-
ate, using Prism (GraphPad Software).
online supplemental material
Fig. S1 shows flow cytometric analysis of monocytes and 
monocyte precursors in the BM. Fig. S2 shows additional 
characterization of cx3cr1Cre :tnf f /f mice. Fig. S3 shows 
microglia-restricted TNF deletion does not affect EAE onset. 
Tables S1 and S2 are included as Excel files. Table S1 lists 
genes up-regulated in spinal cord effector monocytes at EAE 
day 9 compared with Ly6Chi monocytes. Table S2 lists genes 
down-regulated in spinal cord effector monocytes at EAE day 
9 compared with Ly6Chi monocytes.
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Figure S1. Flow cytometric analysis of monocytes and monocyte precursors in the BM. (A) FACS analysis of blood monocytes from nonchimeric 
WT and TNFR1−/− mice in steady state. n = 8. Results are expressed as means ± SEM. (B) FACS analysis illustrating definition of blood monocyte subsets. (C) 
FACS analysis illustrating definition of monocyte precursors. FSC, forward scatter. (D) FACS analysis of myeloid BM precursors: MDPs, cMOPs, and BM Ly6Chi 
monocytes in [TNFR1−/−/WT > WT] mixed BM chimeras. (E) FACS analysis of indicated myeloid BM precursors in [TNF/WT > WT] mixed BM chimeras as in F. 
Mo, monocyte. (F) FACS analysis of colons of [CD45.2 TNF−/−/CD45.1 WT > WT] mice treated with 2% DSS for 7 d. Each mouse was assessed for frequency 
of CD45.2+ steady-state blood monocytes before DSS administration, as in Fig. 1 E. n = 5. *, P < 0.05; Mann-Whitney U test was used.
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Figure S2. Additional characterization of cx3cr1Cre :tnf f /f mice. (A) FACS analysis of intracellular TNF expression in different myeloid populations in the 
inflamed spinal cord of tnf f/f and cx3cr1cre :tnf f /f mice. MG, microglia. (B) Pooled day-of-onset (left) and maximal-score (right) data of MOG35–55-immunized 
tnf f/f and cx3cr1cre :tnf f /f mice from three independent experiments. n = 14. *, P < 0.05. Student’s t test was used. (C) FACS analysis of blood monocytes 
from tnf f/f and cx3cr1cre :tnf f /f mice in steady state. n = 8–7. (D) FACS analysis of CD45hiLy6ChiMHC II+ effector monocytes (gated as in Fig. 3 A) from spinal 
cords of MOG35–55-immunized tnf f/f and cx3cr1cre :tnf f /f mice 24 d after immunization (the same cells are shown also in Fig. 4 C). n = 4–7. (E) Histological 
analysis of demyelination by luxol-fast blue stain in spinal cords of in tnf fl/fl and cx3cr1Cre :tnf fl /fl mice at day 24 after immunization. n = 5–6. (F) FACS 
analysis of Th1 and Th17 cells in lymph nodes (LN) at day 6 after immunization or in spinal cord (SC) at days 13 and 24 in tnf fl/fl and cx3cr1Cre :tnf fl /fl. n = 
4–6. (G) CD3 histological stain in spinal cords of tnf fl/fl and cx3cr1Cre :tnf fl /fl mice at day 24 after immunization. n = 5–6. (E and G) Bars, 100 µm. (H) FACS 
analysis of lymph node T cells of tnf fl/fl and cx3cr1Cre :tnf fl /fl mice immunized with MOG35–55 in vivo and restimulated ex vivo with 10 µg/ml MOG35–55. Shaded 
histograms represent nonstimulated cells. Unshaded histograms represent stimulated cells. n = 3 biological repeats. (I) FACS analysis for the activation 
marker VCAM1 on endothelial cells (CD31+CD45) isolated from spinal cord of tnf fl/fl and cx3cr1Cre :tnf fl /fl mice 9 d after MOG35–55 immunization. n = 6–10. 
Results are expressed as means ± SEM.
S17JEM 
Figure S3. Microglia-restricted TNF deletion does not affect EAE onset. (A) Intracellular FACS staining for TNF expression of microglia isolated 
from tnf fl/fl and cx3cr1CreER :tnf fl /fl animals 6 wk after TAM treatment. Microglia were treated ex vivo with 10 µg/ml LPS for 4  h or left unstimulated. 
Data are representative of three biological repeats. (B) Gating strategy for microglia in the inflamed spinal cord. (C) TNF production by microglia 
(CD11b+CD45intLy6C−Ly6G−) in spinal cords of TAM-treated tnf fl/fl and cx3cr1CreER :tnf fl /fl mice 24 d after MOG35–55 immunization, analyzed by FACS. n = 4–6. 
**, P < 0.01. Mann-Whitney U test was used. (D–F) EAE disease course, individual day of onset, and individual maximal score of TAM-treated tnf fl/fl and 
cx3cr1CreER :tnf fl /fl mice immunized with MOG35–55. n = 5–8. Data are representative of three independent experiments. Results are expressed as means ± 
SEM. (G) Pooled day of onset (left) and maximal score (right) of MOG35–55-immunized tnf f/f and cx3cr1creER :tnf f /f mice from three independent experiments. 
n = 12–14. (H) Mortality rate of pooled tnf f/f and cx3cr1creER :tnf f /f mice shown in G. Numbers indicate the death incidence out of total mice in each group. 
χ test was performed to assess the significance.
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Tables S1 and S2 are included as Excel files. Table S1 lists genes up-regulated in spinal cord effector monocytes at EAE day 9 
compared with Ly6Chi monocytes. Table S2 lists genes down-regulated in spinal cord effector monocytes at EAE day 9 com-
pared with Ly6Chi monocytes.
